Table 4. The gene ontology (GO) analysis of the potential targets of miR-204-5p.
| ID | Term | FDR | Genes |
|---|---|---|---|
| BP | |||
| GO:0030182 | Neuron differentiation | 3.21E-07 | ALS2, NRP2, NRP1, CNP, GRIN3A, RORA, PAX2, PRKG1, GDNF, CXCL12 |
| GO:0048666 | neuron development | 5.90E-07 | ALS2, NRP2, NRP1, CNP, GRIN3A, PAX2, PRKG1, GDNF, CXCL12, ZFP91 |
| GO:0031175 | neuron projection development | 2.27E-06 | NRP2, ALS2, NRP1, CNP, GRIN3A, PAX2, PRKG1, CXCL12, GDNF, BDNF |
| GO:0048812 | neuron projection morphogenesis | 4.34E-05 | NRP2, ALS2, NRP1, LPPR4, ADORA2A, ERBB3, CNP, PAX2, CXCL12, EPHB1 |
| MF | |||
| GO:0003700 | transcription factor activity | 1.02E-05 | MEF2C, MEF2A, HMX2, HMX1, THRB, STAT5B, RORA, PGR, TAF5L, HOXC8 |
| GO:0030528 | transcription regulator activity | 2.00E-05 | MEF2C, MEF2A, STAT5B, MED22, RORA, MXI1, PGR, TAF5L, CREB3L2, ZNF396 |
| GO:0004714 | transmembrane receptor protein tyrosine kinase activity | 0.002602197 | NRP2, RET, NRP1, ERBB4, EFNB3, ERBB3, EFNA3, EPHA10, EPHA1, EPHB1 |
| GO:0043565 | sequence-specific DNA binding | 0.022779507 | ISX, MEF2C, PPARA, HMX2, MEF2A, BACH2, ELF2, HMX1, FOXK1, THRB |
| CC | |||
| GO:0044459 | plasma membrane part | 4.98E-06 | VAPA, IL6ST, RP2, EFNA3, SYT6, GRIN3A, ZNRF1, AQP2, ATP2B1, ATP2B4 |
| GO:0005887 | integral to plasma membrane | 2.50E-04 | MPZL1, KCNC4, IL6ST, SLC6A20, EFNA3, GRIN3A, TLR6, VIPR2, ATP2B1, ATP2B4 |
| GO:0031226 | intrinsic to plasma membrane | 3.67E-04 | MPZL1, KCNC4, IL6ST, SLC6A20, EFNA3, GRIN3A, TLR6, VIPR2, ATP2B1, ATP2B4 |
| GO:0005626 | insoluble fraction | 0.00195022 | ALS2, SEPT3, VAPA, HMGCR, VAPB, ADCY6, SYNCRIP, LEMD3, CNP, RAB1A |
Three parts of GO analysis was included (BP:biological process; MF: molecular function; CC: cellular component). The enriched terms with FDR less than 0.05 of the top 4 were presented.